Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Toast Up As Q2 Results Improve; Annual Sales Outlook Raised
  2. Ali Martinez: Bitcoin in Danger of Falling to $20,590
  3. Bitcoin (BTC) Market Cap Overtakes Berkshire Hathaway and Tesla – Now Among Top 10 Assets Globally
  4. Bloomberg Strategist: Ethereum Is ‘Doing to the World What Netflix Did to Blockbuster’
  5. Volcon Soars As Co. Gets $100 Mln Pre-orders For Its Fully Electric UTV